Kimberly-Clark Acquires Tylenol Maker Kenvue for $48.7 Billion
Reported about 14 hours ago
Kimberly-Clark has announced its acquisition of Kenvue, the maker of Tylenol, in a $48.7 billion deal, resulting in the formation of a major consumer health goods company.